Rezolute (RZLT) Invested Capital (2010 - 2026)
Rezolute's (RZLT) quarterly Invested Capital came in at $116.8 million in Q1 2026, up 41.5% year-on-year from $82.6 million in Q1 2025, and down 8.72% quarter-over-quarter from $128.0 million in Q4 2025.
Rezolute (RZLT) Invested Capital (2010 - 2026) Analysis & Trends
Rezolute has disclosed Invested Capital across 17 years of filings, most recently posting $116.8 million for Q1 2026.
- Invested Capital for Q1 2026 came in at $116.8 million, up 41.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $116.8 million (up 41.5% YoY), and the FY2025 annual result was $162.1 million, up 33.99% from the prior year.
- Invested Capital came in at $116.8 million for Q1 2026 at Rezolute, down from $128.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $162.1 million in Q2 2025 to a low of $66.2 million in Q1 2022.
- The 5-year median for Invested Capital is $116.8 million (2026), against an average of $117.1 million.
- Across the five-year window, Invested Capital soared 329.67% in 2022 and tumbled 44.34% in 2024, its largest moves.
- Rezolute's Invested Capital stood at $141.3 million in 2022, then plunged by 35.07% to $91.7 million in 2023, then gained by 8.57% to $99.6 million in 2024, then climbed by 28.53% to $128.0 million in 2025, then dropped by 8.72% to $116.8 million in 2026.
- The last three Invested Capital figures came in at $116.8 million (Q1 2026), $128.0 million (Q4 2025), and $147.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 116.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.83 Mn |
| Dec 31, 2025 | 128.00 Mn |
| Sep 30, 2025 | 147.17 Mn |
| Jun 30, 2025 | 162.13 Mn |
| Mar 31, 2025 | 82.57 Mn |
| Dec 31, 2024 | 99.59 Mn |
| Sep 30, 2024 | 113.44 Mn |
| Jun 30, 2024 | 121.00 Mn |
| Mar 31, 2024 | 70.86 Mn |
| Dec 31, 2023 | 91.73 Mn |
| Sep 30, 2023 | 103.56 Mn |
| Jun 30, 2023 | 116.17 Mn |
| Mar 31, 2023 | 127.32 Mn |
| Dec 31, 2022 | 141.27 Mn |
| Sep 30, 2022 | 153.09 Mn |
| Jun 30, 2022 | 149.47 Mn |
| Mar 31, 2022 | 66.19 Mn |
| Dec 31, 2021 | 76.44 Mn |
| Sep 30, 2021 | 35.63 Mn |
| Jun 30, 2021 | 40.07 Mn |